Protara Therapeutics
Price & Volume
Stats
See moreOpen | $3.50 |
Previous Close | $3.54 |
Day Range | $3.31-$3.50 |
52W Range | $3.44-$7.82 |
Market Cap | $217.4M |
Shares Short | 4M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.43 |
News
See moreYahoo Finance • 4 months ago
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
Yahoo Finance • 7 months ago
Protara Therapeutics GAAP EPS of -$0.37
Yahoo Finance • 7 months ago
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Yahoo Finance • 7 months ago
Protara Therapeutics to Participate in Upcoming Investor Conferences
About
CEO | Mr. Jesse Shefferman |
Address | 345 Park Avenue South, New York, NY, United States, 10010 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 46 |